Fady T Botros
4PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 29, 2024
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.Richard M Bergenstal, Athena Philis-Tsimikas, Carol Wysham
|Jun 21, 2023
Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis.Fady T Botros, Hertzel C Gerstein, Raleigh Malik
|May 13, 2022
Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial.Edward Franek, Hertzel C Gerstein, Matthew C Riddle
|Feb 15, 2019
Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7).Katherine R Tuttle, Mark C Lakshmanan, Brian Rayner
Pageof 1
Frequent Collaborators
2 joint publications
Hertzel C Gerstein
1 joint publications
Matthew C Riddle
1 joint publications
Li Shen Loo
1 joint publications
Helen M Colhoun
1 joint publications
Richard M Bergenstal
1 joint publications
Carol Wysham
1 joint publications
Juliana M Bue-Valleskey
1 joint publications
Thomas Blevins
1 joint publications
Julio Rosenstock
